Toyota Kirloskar Motor (TKM) has announced the commencement of three-shift operations at its manufacturing facility in Bidadi from May 2023 due to rising demand for its existing portfolio of products and new launches in 2022.
IDA is a significant burden for women, especially during later trimesters and due to postpartum hemorrhage (PPH). Indian studies have indicated that most patients need FCM 1500 mg at body weight between 35-70 kgs. A single dose of FCM up to 750 mg of iron can be infused in a short time frame of 15 minutes diluted in 250 ml of normal saline. TKM has focused on maximizing plant efficiency and embracing cutting-edge technologies, such as the e-Drive manufacturing line at TKAP. Toyota Environmental Challenge (TEC) 2050 has been inspired by sustainability and is committed to a greener future.
Toyota has adopted various environmental risk mitigating measures, such as the Plant Zero CO2 Emissions Challenge, to achieve zero CO2 emissions at their manufacturing facilities. Additionally, the adoption of alternative renewable energy sources has been a significant step towards energy management. Emcure Pharmaceuticals Limited aims to address the unmet medical needs of IDA patients in India by providing reliable and convenient treatment options.Mr. Sudeep Dalvi, SVP & Chief Communication Officer, Toyota Kirloskar Motor said, “Together, we strive to deliver Mass Happiness to All”.
